Digital health—United Kingdom—Q&A guide

The following Life Sciences practice note provides comprehensive and up to date legal information covering:

  • Digital health—United Kingdom—Q&A guide
  • 1. Who are the key players active in your local digital health market and what are the most prominent areas of innovation?
  • 2. How would you describe the investment climate for digital health technologies in your jurisdiction, including any noteworthy challenges?
  • 3. What are the most notable recent deals in the digital health sector in your jurisdiction?
  • 4. What due diligence issues should investors address before acquiring a stake in digital health ventures?
  • 5. What financing structures are commonly used by digital health ventures in your jurisdiction? Are there any notable government financing or other support initiatives to promote development of the digital health space?
  • 6. What principal legislation governs the digital health sector in your jurisdiction?
  • 7. Which notable regulatory and enforcement bodies have jurisdiction over the digital health sector?
  • 8. What licensing and authorisation requirements and procedures apply to the provision of digital health products and services in your jurisdiction?
  • 9. Is there any notable ‘soft’ law or guidance governing digital health?
  • More...

Digital health—United Kingdom—Q&A guide

This Practice Note contains a jurisdiction-specific Q&A guide to digital health in United Kingdom published as part of the Lexology Getting the Deal Through series by Law Business Research (published: June 2021).

Authors: Latham & Watkins LLP—Robbie McLaren; Frances Stocks Allen; Oliver Mobasser; Sara Patel; Mihail Krepchev

1. Who are the key players active in your local digital health market and what are the most prominent areas of innovation?

The UK has an active digital health market comprising both the private and public sectors, as well as investors. The National Health Service (NHS) is the dominant buyer in the UK's £5 billion healthcare IT and digital market, with the private sector only accounting for spend of approximately £250 million annually. NHS trusts can also currently apply for a share of £50 million in grant funding to scale up digital pathology, radiology and AI capabilities in England.

The digital health market in the UK focuses predominantly on:

  1. telehealth;

  2. mHealth (or mobile health);

  3. analytics, diagnostics and big data;

  4. digitised health systems; and

  5. R&D and genomics.

Each of these sectors has seen vast growth since March 2020 due to the covid-19 pandemic.

Examples of the key participants in the UK digital health market include:

  1. Babylon;

  2. Benevolent AI;

  3. Congenica;

  4. Vernalis;

  5. DoctorLink;

  6. Cera;

  7. Huma; and

  8. LumiraDx.

Academic institutions, such as the University of Oxford, the University of Cambridge, the University of Edinburgh and

Popular documents